Facebook Linkedin RSS Twitter Youtube
Home 2024

Spatial transcriptomic

Aiming High: 10x, NanoString Launch Large-Scale Panels
GEN Edge

Aiming High: 10x, NanoString Launch Large-Scale Panels

Spatial Transcriptomics Platform Promises Low-Cost, High-Res 3D Mapping
Cancer

Spatial Transcriptomics Platform Promises Low-Cost, High-Res 3D Mapping

Court Grants Vizgen Motion to Expand Antitrust Case vs.10x, Harvard
GEN Edge

Court Grants Vizgen Motion to Expand Antitrust Case vs.10x, Harvard

Bruker to Acquire NanoString with $392.6M Winning Bid
GEN Edge

Bruker to Acquire NanoString with $392.6M Winning Bid

As 10x Launches Visium HD, Will Single Cell Resolution Draw New Customers?
GEN Edge

As 10x Launches Visium HD, Will Single Cell Resolution Draw New Customers?

10x Ships First Single Cell GEM-X Assays to Customers
GEN Edge

10x Ships First Single Cell GEM-X Assays to Customers

NanoString Agrees to be Acquired by Investment Firm for $220M
GEN Edge

NanoString Agrees to be Acquired by Investment Firm for $220M

Brain Tumors, Infections May Have an Achilles’ Heel … in the Eye
Cancer

Brain Tumors, Infections May Have an Achilles’ Heel … in the Eye

NanoString CSO Joe Beechem Insists the Company “Not Going Anywhere”
Industry News

NanoString CSO Joe Beechem Insists the Company “Not Going Anywhere”

NanoString Files for Chapter 11 Bankruptcy, Launches Strategic Review
News

NanoString Files for Chapter 11 Bankruptcy, Launches Strategic Review

123Page 1 of 3
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.